Discovering new levels of agility with hybrid-cloud self-service and DevOps automation - AstraZeneca

For businesses seeking new levels of agility and efficiency in hybrid-cloud management, HPE Morpheus proves to be a game-changer. This week's case study delves into how global biopharmaceutical firm AstraZeneca overhauled their hybrid-cloud systems using HPE Morpheus. The result? A staggering 177x improvement in end-to-end deployment times and initial savings in excess of $2.4M through reduced labor costs and delay minimization. Fast response times are vital in the pharmaceutical segment, and implementing HPE Morpheus helped streamline AstraZeneca's processes, enabling them to deliver more value faster and compete more effectively. The platform's advanced hybrid-cloud automation and self-service features not only allowed the firm to keep up with constantly changing business demands but also led to provisioning savings exceeding $6M. Read the case study to learn how your infrastructure can be similarly transformed with the help of our reseller services. Contact us to learn more and get started today!

View FAQs
Frequently Asked Questions

What challenges did AstraZeneca face in their IT processes?

How did HPE Morpheus Enterprise improve AstraZeneca's operations?

What benefits did AstraZeneca gain from increased automation?

Discovering new levels of agility with hybrid-cloud self-service and DevOps automation - AstraZeneca published by TechProc

TechProc is a Certified Minority Owned and Operated IT solutions provider/Integrator focused on Digital Infrastructure, Cloud, Cybersecurity & Emerging solutions. We deliver this technology expertise through a full life cycle model of professional, managed, and support services, including strategy, consulting, implementation, and design. By taking the time to deeply understand our client's needs, we help them harness technology advances, simplify IT complexity, and optimize their environments today while enabling future applications and user experiences.